ATLAS / Macro Radar / Reporting / NAMS

NewAmsterdam Pharma Co N.V. (NAMS) reporting calendar

NewAmsterdam Pharma Co N.V. files periodic reports with the SEC as NAMS on Nasdaq. Atlas tracks 12 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
27 Jul 2026 – 16 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
12

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 37 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open NAMS market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001193125-26-210272
10-K31 Dec 202518 Feb 202649 days0001193125-26-056029
10-Q30 Sep 20255 Nov 202536 days0001193125-25-265796
10-Q30 Jun 20256 Aug 202537 days0000950170-25-103521
10-Q31 Mar 20258 May 202538 days0000950170-25-066413
10-K31 Dec 202426 Feb 202557 days0000950170-25-027339
10-Q30 Sep 20246 Nov 202437 days0000950170-24-121828
10-Q30 Jun 20247 Aug 202438 days0000950170-24-092281
10-Q31 Mar 20248 May 202438 days0000950170-24-055767
10-K31 Dec 202328 Feb 202459 days0000950170-24-021668
20-F31 Dec 202231 Mar 202390 days0000950170-23-011412
20-F22 Nov 202228 Nov 20226 days0001193125-22-293435

Source: SEC EDGAR company submissions for CIK 0001936258. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.